Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control studyBijal Shah, Roch Houot, Olalekan O. Oluwole et al.|Journal of Hematology & Oncology|2022Cited by 78